Shouyao Holdings (Beijing) Co. Ltd. A

SHG:688197 China Biotechnology
Market Cap
$762.32 Million
CN¥5.59 Billion CNY
Market Cap Rank
#13220 Global
#3363 in China
Share Price
CN¥37.61
Change (1 day)
-0.42%
52-Week Range
CN¥27.20 - CN¥55.94
All Time High
CN¥66.15
About

Shouyao Holdings (Beijing) Co., LTD. engages in the research, development, and production of innovative drugs in China. The company offers drugs for various indications, including non-small cell lung cancer, lymphoma, hepatocellular carcinoma, pancreatic cancer, breast cancer, ovarian cancer, thyroid cancer, leukemia, and diabetes. The company was founded in 2016 and is headquartered in Beijing, … Read more

Shouyao Holdings (Beijing) Co. Ltd. A (688197) - Total Liabilities

Latest total liabilities as of June 2025: CN¥114.81 Million CNY

Based on the latest financial reports, Shouyao Holdings (Beijing) Co. Ltd. A (688197) has total liabilities worth CN¥114.81 Million CNY as of June 2025.

Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Shouyao Holdings (Beijing) Co. Ltd. A - Total Liabilities Trend (2019–2024)

This chart illustrates how Shouyao Holdings (Beijing) Co. Ltd. A's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.

Shouyao Holdings (Beijing) Co. Ltd. A Competitors by Total Liabilities

The table below lists competitors of Shouyao Holdings (Beijing) Co. Ltd. A ranked by their total liabilities.

Company Country Total Liabilities
Bénéteau S.A
OTCGREY:BTEAF
USA $766.45 Million
Wanma Technology Co Ltd
SHE:300698
China CN¥627.12 Million
Xinlong Holding Group Co Ltd
SHE:000955
China CN¥152.91 Million
Tianjin Jiuri New Materials Co Ltd
SHG:688199
China CN¥1.49 Billion
Timberland Bancorp Inc
NASDAQ:TSBK
USA $1.74 Billion
Primis Financial Corp
NASDAQ:FRST
USA $3.62 Billion
Takara Bio Inc
F:TF2
Germany €29.21 Billion
APG SGA SA
SW:APGN
Switzerland CHF93.01 Million

Liability Composition Analysis (2019–2024)

This chart breaks down Shouyao Holdings (Beijing) Co. Ltd. A's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 6.16 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.16 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.14 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Shouyao Holdings (Beijing) Co. Ltd. A's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Shouyao Holdings (Beijing) Co. Ltd. A (2019–2024)

The table below shows the annual total liabilities of Shouyao Holdings (Beijing) Co. Ltd. A from 2019 to 2024.

Year Total Liabilities Change
2024-12-31 CN¥113.21 Million +24.20%
2023-12-31 CN¥91.16 Million -1.70%
2022-12-31 CN¥92.73 Million +63.62%
2021-12-31 CN¥56.67 Million +58.70%
2020-12-31 CN¥35.71 Million -19.44%
2019-12-31 CN¥44.33 Million --